About Haukeland University Hospital, Klinisk Forskningspost
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Haukeland University Hospital, Klinisk Forskningspost
During the past decade, Haukeland University Hospital, Klinisk Forskningspost conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
2016-02-24
2019-07-01
Terminated
732
Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis
2015-11-17
2018-01-18
Completed
160
MAGNOLIA: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301
2017-12-13
2018-05-22
Completed
33
LUMINA Phase III Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 Sirolimus for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye
2018-11-19
2022-06-08
Terminated
146
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Haukeland University Hospital, Klinisk Forskningspost"
#1 collaborator was "Vaccibody AS" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Haukeland University Hospital, Klinisk Forskningspost
According to Clinical.Site data, the most researched conditions in "Haukeland University Hospital, Klinisk Forskningspost" are
"Fabry Disease" (2 trials), "COVID-19" (1 trials), "Infection Viral" (1 trials) and "Infections" (1 trials). Many other conditions were trialed in "Haukeland University Hospital, Klinisk Forskningspost" in a lesser frequency.
Clinical Trials Intervention Types at Haukeland University Hospital, Klinisk Forskningspost
Most popular intervention types in "Haukeland University Hospital, Klinisk Forskningspost" are "Biological" (2 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "PRX-102 (pegunigalsidase alfa)" (1 trials), "VB10.2129" (1 trials), "VB10.2210" (1 trials), "agalsidase beta" (1 trials) and "pegunigalsidase alfa" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Haukeland University Hospital, Klinisk Forskningspost
The vast majority of trials in "Haukeland University Hospital, Klinisk Forskningspost" are
3 trials for "All" genders.
Clinical Trials Status at Haukeland University Hospital, Klinisk Forskningspost
Currently, there are NaN active trials in "Haukeland University Hospital, Klinisk Forskningspost".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Haukeland University Hospital, Klinisk Forskningspost,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Haukeland University Hospital, Klinisk Forskningspost, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".